Critically Ill COVID-19 Patients Make Quick Recovery With New Treatment; Trump Cuts off COVID Question by CNN’s Jim Acosta: ‘Fake News CNN, Hold It’ (VIDEO)

By New York Post. Critically ill COVID-19 patients recovered rapidly from respiratory failure after three days of treatment with RLF-100, a therapy granted fast-track designation in the United States, two drug companies said Sunday.

Geneva-based Relief Therapeutics Holdings AG RFLB.S has a patent for RLF-100, or aviptadil, a synthetic form of a natural peptide that protects the lung. US-Israeli NeuroRx Inc. partnered with Relief to develop the drug in the United States.

In June the US Food and Drug Administration granted fast-track designation to RLF-100 for treatment of respiratory distress in COVID-19.

While a Phase 2/3 clinical trial with 70 patients is ongoing, RLF-100 is being administered on an emergency basis to some patients who are too ill to be admitted to the trial. (Read more from “Critically Ill COVID-19 Patients Make Quick Recovery With New Treatment” HERE)

_______________________________________________

Trump Cuts off Question by CNN’s Jim Acosta About U.S. Coronavirus Death Rate: ‘Fake News CNN, Hold It’

By Fox News. President Trump told CNN reporter Jim Acosta to “hold it” on Monday when the latter asked him about the coronavirus death rate in the U.S. as it compared to other nations.

“The U.S. has so many deaths compared to so many countries around the world,” Acosta said. Trump, in a reprise of his long-running criticism of the network, responded: “Fake News CNN, hold it.”

(Read more from “Trump Cuts off Question by CNN’s Jim Acosta About U.S. Coronavirus Death Rate: ‘Fake News CNN, Hold It'” HERE)

Follow Joe Miller on Twitter HERE and Facebook HERE